Researchers are increasingly focusing on the gut microbiome as a key factor in cancer prevention and treatment. The trillions of microorganisms living in the digestive system not only help regulate digestion but also play an important role in shaping the body's immune response. Scientists believe these microbes may influence how effectively the body recognizes and attacks cancer cells.

According to CNN, growing evidence suggests that the composition of gut bacteria can affect the success of cancer therapies, particularly immunotherapy. Certain beneficial bacteria appear to support immune activity against tumors, while an imbalance in the microbiome may weaken the body's ability to respond to treatment.

Researchers are also investigating whether modifying the gut microbiome through diet, probiotics, prebiotics, or other interventions could improve treatment outcomes. Several studies have found that patients with healthier and more diverse microbial communities may experience stronger immune responses and better therapeutic results.

While scientists caution that more clinical research is needed, the microbiome is emerging as a promising area of cancer research. Experts hope future treatments may use gut bacteria profiles to predict treatment responses and develop more personalized cancer care strategies.